Question 78

The prescription appears to contain a look-alike/sound-alike error

The pharmacy technician should alert the pharmacist because lamivudine is not typically used for seizures, indicating a potential look-alike/sound-alike error in the prescription.

A) the prescription appears to contain a look-alike/sound-alike error

This option is correct as lamivudine is primarily an antiretroviral medication used in the treatment of HIV and is not indicated for seizures. The technician's alert to the pharmacist could prevent a serious medication error.

B) lamivudine requires special handling

This option is incorrect because lamivudine does not require any special handling that would warrant alerting the pharmacist in this context. The handling of lamivudine is standard and does not pose any unique risks.

C) the prescription exceeds the maximum recommended daily dose

This option is incorrect as the prescribed dose of 100 mg once daily does not exceed the recommended daily dosage for lamivudine. The maximum dosage for adult patients is typically higher, so this is not a valid concern.

D) lamivudine is subject to a REMS program

This option is incorrect because lamivudine is not subject to a Risk Evaluation and Mitigation Strategy (REMS) program. REMS programs are typically required for medications with specific risks, which does not apply to lamivudine.

Conclusion

The correct choice highlights a potential medication error, emphasizing the importance of verifying prescriptions to ensure patient safety. Options B, C, and D do not apply to lamivudine in this context, thus reinforcing the necessity of alerting the pharmacist about the unusual indication for its use in this prescription.